The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy.
 
Shilpa Gupta
Consulting or Advisory Role - Exelixis; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Pfizer
Research Funding - Astellas Medivation (Inst); Innocrin Pharma (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst)
 
Neeraj Agarwal
Consulting or Advisory Role - Cerulean Pharma; Clovis Oncology; Eisai; EMD Serono; Exelixis; Genentech/Roche; Medivation/Astellas; Merck; Novartis; Pfizer
Research Funding - Amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Badrinath R. Konety
Consulting or Advisory Role - MDxHealth
Research Funding - FKD Therapies (Inst); Genomic Health (Inst); Photocure (Inst); Roche/Genentech (Inst)
 
Christopher J. Weight
Speakers' Bureau - Abbott Molecular
Research Funding - Myriad Genetics (Inst); Urogen pharma (Inst)
Travel, Accommodations, Expenses - Abbott Molecular
 
Bharat Thyagarajan
No Relationships to Disclose
 
Paari J Murugan
No Relationships to Disclose
 
Joseph S Koopmeiners
No Relationships to Disclose
 
Guru Sonpavde
Honoraria - UpToDate
Consulting or Advisory Role - Agensys; Amgen; Argos Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Janssen; Merck; Novartis; Pfizer; Sanofi
Speakers' Bureau - Clinical Care Options/NCCN
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Onyx (Inst); Pfizer (Inst)
Other Relationship - Boehringer Ingelheim